Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways
about
The evolution of poxvirus vaccinesA Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV ImmunogenThe influence of delivery vectors on HIV vaccine efficacyVirological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.Enhancement of CD8(+) T-cell memory by removal of a vaccinia virus nuclear factor-κB inhibitor.Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript Decapping.Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve ImmunogenicityInhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence.Deletion of A44L, A46R and C12L Vaccinia Virus Genes from the MVA Genome Improved the Vector Immunogenicity by Modifying the Innate Immune Response Generating Enhanced and Optimized Specific T-Cell Responses.Enhancing poxvirus vectors vaccine immunogenicity.Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators.Effects of alpha interferon treatment on intrinsic anti-HIV-1 immunity in vivo.Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.Clinical applications of attenuated MVA poxvirus strain.HIV vaccines: a brief overview.A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-SpeciGeneration of an Attenuated Tiantan Vaccinia Virus Strain by Deletion of Multiple Genes.Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?Immune Modulation of NYVAC-Based HIV Vaccines by Combined Deletion of Viral Genes that Act on Several Signalling Pathways.CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory.Distinct Immunogenicity and Efficacy of Poxvirus-based Vaccine Candidates against Ebola Virus expressing GP and VP40 Proteins.The Gene of Goatpox Virus Encodes an Inhibitor of NF-κB and Apoptosis and May Serve as an Improved Insertion Site To Generate Vectored Live VaccineDNA-launched RNA replicon vaccines induce potent anti-Ebolavirus immune responses that can be further improved by a recombinant MVA boostRemoval of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression
P2860
Q26995905-636396AD-0376-49E7-A13C-1B884B17A98CQ27302081-9DD7590D-B9AC-4F11-862F-F361017E2201Q34077543-359C6A2F-F693-4FCC-8C12-C5D641138A41Q34991112-B7D70999-A5B8-4B05-961F-8FC84AC017E4Q35512353-773E0408-2858-471B-ACBE-94562F3CDB7FQ35642108-F055EB0A-62A7-44A3-B1DE-31991FB523BFQ35656345-72B5F1FC-958F-4D4E-8D0A-4374A10AAC8CQ35763016-D6EECF74-41CD-4911-83FF-7FD1B007150AQ36947039-BC17718B-4B64-45A7-8781-5A1CEAF53EFCQ36978452-19A42ADE-1700-4DA7-9B9F-3398023F37CFQ37255121-2B66BA8A-D2E7-42E3-8B1E-7E36C89275C0Q37547692-3ADE0E6A-7182-4345-A478-EC062BDC8FF2Q37643731-0D2A17CE-A479-4560-B24B-CE104F004C81Q37643733-C2C00EB5-84F0-4BC0-99C5-1C4410C5B11EQ38156198-806CAB2D-5723-44B3-9DEB-C6C99CDBF6F3Q38210557-DBCF7887-A864-4DE6-AE84-EA40CFCF321CQ40220988-089981AB-F6AF-43FA-AC40-807F74F747BAQ40339467-CD38940F-0950-46B2-8292-13555C71E659Q45324442-7DAED266-1678-4B78-8C50-6619C5027316Q45325213-E10019FA-C8AA-43F1-B3A6-259EAAD9997CQ47252143-9AB6918D-7AEA-4A13-868F-1CFEF544F63AQ47549689-595614AB-2496-479B-A8D3-0BFC969E2EFEQ50533334-B013A281-1075-49AA-A9A1-B7CA885D9BA1Q51784219-89C9908D-967F-43C8-9671-2C9E72240185Q56556724-5D2B1ABC-BEAB-4B4B-897C-0CC39EF82837Q56973287-FD83BC83-113A-49B1-8D0E-51E5CC343DAEQ56987707-B235C4FA-FCD2-46C2-9838-670EC04D4F74
P2860
Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Improving Adaptive and Memory ...... Interferon Signaling Pathways
@ast
Improving Adaptive and Memory ...... Interferon Signaling Pathways
@en
Improving Adaptive and Memory ...... letion of Vaccinia Virus Genes
@nl
type
label
Improving Adaptive and Memory ...... Interferon Signaling Pathways
@ast
Improving Adaptive and Memory ...... Interferon Signaling Pathways
@en
Improving Adaptive and Memory ...... letion of Vaccinia Virus Genes
@nl
prefLabel
Improving Adaptive and Memory ...... Interferon Signaling Pathways
@ast
Improving Adaptive and Memory ...... Interferon Signaling Pathways
@en
Improving Adaptive and Memory ...... letion of Vaccinia Virus Genes
@nl
P2093
P2860
P1433
P1476
Improving Adaptive and Memory ...... Interferon Signaling Pathways
@en
P2093
Carlos Óscar S Sorzano
Carmen E Gómez
Mariano Esteban
Pilar Arnáez
P2860
P304
P356
10.1371/JOURNAL.PONE.0066894
P407
P577
2013-06-27T00:00:00Z